Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Retinal ultrastructural, electrophysiological and microvascular morphological outcomes in diabetic macular edema treated with intravitreal Bevacizumab

Show simple item record

dc.contributor.author Gulyesil, Furkan Fatih
dc.contributor.author Inan, Sibel
dc.contributor.author Sabaner, Mehmet Cem
dc.contributor.author Alizade, Anar
dc.contributor.author Gobeka, Hamidu Hamisi
dc.date.accessioned 2023-04-12T07:02:31Z
dc.date.available 2023-04-12T07:02:31Z
dc.date.issued 2021
dc.identifier.citation GULYESIL, Furkan Fatih, INAN, Sibel, SABANER, Mehmet Cem, ALIZADE, Anar, GOBEKA, Hamidu Hamisi. Retinal ultrastructural, electrophysiological and microvascular morphological outcomes in diabetic macular edema treated with intravitreal Bevacizumab. In: 19th Black Sea Ophthalmological Society Congress, September 24-26, 2021, Chisinau, Republic of Moldova: abstract book, p. 62. en_US
dc.identifier.uri https://aom.md/wp-content/uploads/2021/10/ABSTRACT-BOOK_web.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/24106
dc.description.abstract Purpose: To investigate retinal ultrastructural, electrophysiological, and microvascular morphological changes, as well as correlations between these changes and visual outcome in naïve diabetic macular edema (DME) patients after intravitreal bevacizumab therapy Design: A prospective interventional study Methods: A total of 31 DME patients’ eyes had monthly intravitreal bevacizumab injections for three consecutive months. Best-corrected visual acuity (BCVA) and intraocular pressure (IOP) were measured, and fundus fluorescein angiography, optical coherence tomography (OCT), microperimetry (MP), as well as optical coherence tomography angiography (OCTA) were performed before and after therapy. Patients were then grouped based on BCVA improvement after three consecutive intravitreal injections: group 1- >10 letters, group 2- ≤5 letters, and group 3- between 6 and 10 letters. Results: Mean BCVA increased significantly after therapy, rising from 34.2 to 39.9 letters (p<0.001). The central macular thickness (CMT) decreased significantly from baseline 335.1 μm to 276.4 μm (p<0.001). Fixation stability, mean retinal sensitivity, and mean local deficit all improved significantly after therapy (p<0.001 for all). There was no statistically significant change in IOP before and after therapy (p=0.665). While OCTA parameters did not change significantly, patients with lower foveal avascular zone area, higher FD-300 and deep plexus vascular density showed better improvements in mean BCVA, retinal sensitivity, and local defect. Also, there were no significant intergroup differences in gender, age, baseline BCVA, HbA1c, IOP, phakic/pseudophakic lens ratio, presence of concomitant hypertension, and superficial capillary plexus vascular density. Conclusions: Intravitreal bevacizumab therapy was associated with significantly improved BCVA, retinal ultrastructural integrity, and electrophysiological patterns in naive DME patients. Improvements in retinal electrophysiology correlated with ultrastructural improvements, which could be predicted using OCTA. en_US
dc.language.iso en en_US
dc.publisher Black Sea Ophthalmological Society, Ophthalmological Association from Moldova, Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova en_US
dc.relation.ispartof 19th Black Sea Ophthalmological Society Congress, September 24-26, 2021 Chisinau, Republic of Moldova en_US
dc.title Retinal ultrastructural, electrophysiological and microvascular morphological outcomes in diabetic macular edema treated with intravitreal Bevacizumab en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics